Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Elena Vigorito(University of Cambridge), Anne‐Marie Gerdes(Copenhagen University Hospital), Florentia Fostira(National Centre of Scientific Research "Demokritos"), Judy E. Garber(Dana-Farber Cancer Institute), Jackie Cook(Sheffield Children's Hospital), Francesca Damiola(Centre Léon Bérard), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Karoline Kuchenbaecker(University of Cambridge), Banu Arun(The University of Texas Health Science Center at Houston), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Julian Adlard(Chapel Allerton Hospital), Salina Chan(University of California, San Francisco), Kathleen Claes(Statistics Belgium), William D. Foulkes(McGill University Health Centre), Eitan Friedman(University of Pennsylvania), Anders Bojesen(Vejle Sygehus), Ian Campbell(The University of Sydney), Capucine Delnatte(Laboratoire de Génétique Cellulaire), Antoine De Pauw, Laure Barjhoux(Centre Léon Bérard), Douglas F. Easton(University of Cambridge), Irene L. Andrulis(University of Toronto), Javier Benı́tez(Spanish National Cancer Research Centre), Pragna Gaddam, Bjarni A. Agnarsson(Reykjavík University), Martine Dumont, Susan M. Domchek(University City Science Center), Ardnor Christina Edwinsdotter, Bernardo Bonanni(European Institute of Oncology), Lídia Feliubadaló(University of Cologne), D. Gareth Evans(Manchester Academic Health Science Centre), Vanesa García‐Barberán, David E. Cohn(The Ohio State University), Patricia A. Ganz(Los Angeles County Department of Public Health), Bernd Dworniczak(University Hospital Münster), Katarzyna Durda(Pomeranian Medical University), Mary B. Daly(Fox Chase Cancer Center), Rosemarie Davidson(The Netherlands Cancer Institute), Andreas Berger(Comprehensive Cancer Center Vienna), Carole Brewer(Royal Devon and Exeter Hospital), Bent Ejlertsen(Copenhagen University Hospital), Marion Gauthier‐Villars, Muriel Belotti(Institut Curie), Andrea Gehrig(University of Würzburg), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Debra Frost(University of Cambridge), Orland Dı́ez(Vall d'Hebron Hospital Universitari), Diana Eccles(Princess Anne Hospital), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana)
Cited by 0
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k